AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Insulet Corp.
Video analysis: PODD
All videosNo video analysis for this stock yet. Request one from our team.
News: PODD
California State Teachers Retirement System Has $2.22 Billion Stock Position in Insulet Corporation $PODD
California State Teachers Retirement System grew its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 13,901.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,562,256 shares of the medical instruments supplier's stock after acquiring an additional 14,458,254
Insulet Corporation $PODD Stock Position Raised by Amundi
Amundi increased its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 13.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 507,847 shares of the medical instruments supplier's stock after acquiring an additional 60,929 shares during the quarter. Amundi
Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Here's Why Insulet (PODD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.
Insulet (PODD) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?
Insulet (PODD) reported earnings 30 days ago. What's next for the stock?
Baron SMID Cap ETF Q2 2026 Portfolio Activity
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus electrons" software provider with huge competitive moats. We sold the HeartFlow position in the quarter as we grew incrementally more concerned with the presence of competitors on the market.
Similar companies
-
DexCom, Inc.
DXCM
·
NASDAQ
Compare
-
STERIS plc
STE
·
New York Stock Exchange
Compare
-
Koninklijke Philips N.V.
PHG
·
New York Stock Exchange
Compare
-
Zimmer Biomet Holdings, Inc.
ZBH
·
New York Stock Exchange
Compare
-
Biogen Inc.
BIIB
·
NASDAQ
Compare
-
Labcorp Holdings Inc.
LH
·
New York Stock Exchange
Compare